FGF21 derivatives with albumin binder A-B-C-D-Eand their use

Details for Australian Patent Application No. 2010207721 (hide)

Owner Novo Nordisk A/S

Inventors Tagmose, Tina Moller; Garibay, Patrick William; Andersen, Birgitte; Wang, Jishu; Conde Frieboes, Kilian Waldemar; Bak-Jensen, Kristian Sass; Thogersen, Henning; Woldike, Helle; Nielsen, Peter Kresten; Slaaby, Rita; Zhang, Xujia; Wieczorek, Birgit

Agent Shelston IP

Pub. Number AU-A-2010207721

PCT Pub. Number WO2010/084169

Priority 09164904.6 08.07.09 EP; 09151227.7 23.01.09 EP; 09152144.3 05.02.09 EP

Filing date 22 January 2010

Wipo publication date 29 July 2010

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/084169 Priority application(s): WO2010/084169

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010207725-Stable growth hormone compounds

2010207720-Solar thermal device for producing fresh water